SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SPCX is experiencing extreme volatility and intense debate as investors weigh the impact of upcoming insider lock-up expirations against the company's long-term AI and aerospace infrastructure ambitions. The community remains sharply divided between short sellers betting on further downside and bulls who view the recent sell-off as a prime entry point for a sector leader.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk Corp (SNDK) is experiencing intense volatility and a sharp downward slide as part of a broader rout in the semiconductor and memory sectors, fueled by concerns over Chinese competition and heavy institutional profit-taking. The community is sharply divided between "bottom fishers" looking to capitalize on perceived oversold levels before upcoming earnings and skeptical traders who view the recent parabolic rally as a bubble that has finally burst.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Singapore.

Seagate Technology Holdings Plc

Seagate is experiencing heightened volatility and intense community scrutiny as investors weigh its role in the AI storage bottleneck against recent technical pullbacks and institutional settlement news. Market participants are actively debating whether the stock's recent price action represents a healthy consolidation within a long-term AI-driven growth cycle or a deeper structural reset for the data storage sector.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is currently capturing significant market attention following a stellar earnings report that highlighted accelerating AI demand, record operating margins, and increased guidance. Investors are actively debating the company's valuation against its massive year-over-year revenue growth, with community sentiment largely focused on its crucial role in the AI server infrastructure supply chain.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending amid intense investor debate over the escalating geopolitical conflict in the Middle East and its impact on global energy supplies. While some traders are betting on further upside due to potential supply disruptions in the Strait of Hormuz, others are focused on volatility triggered by diplomatic headlines and official statements regarding potential ceasefire efforts.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently rallying as investors rotate back into AI infrastructure plays, supported by recent analyst upgrades that highlight its strategic role in meeting massive data center power demand. While the stock continues to experience high volatility, market participants are actively debating the impact of ongoing institutional call buying against concerns over supply chain transparency and sector-wide macro headwinds.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trending due to a significant regulatory pivot, as the company secured an agreement with the FDA to resubmit its BLA for RP1 in advanced melanoma, sparking investor optimism regarding the potential for approval after two prior rejections. The community is actively debating the reliability of this path forward, with discussions centered on potential political influence versus scientific merit, concerns about the company's financial stability, and high levels of short interest driving intense volatility.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display, Specialty Materials, Automotive, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computers, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Automotive segment manufactures ceramic substrates and filter products for emissions control in mobile applications around the world as well as technical glass and optic products and solutions for the interior and exterior of vehicles. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Corning, Inc. (GLW) shares are under heavy selling pressure as investors aggressively rotate out of the AI infrastructure sector, causing significant volatility despite the company's long-term partnerships in data center and optical connectivity. While the community remains divided between those viewing the rapid decline as a technical overreaction and buying opportunity versus those concerned about unsustainable valuation and momentum unwinding, many are closely watching for a stabilization point near key technical support levels.

JetBlue Airways Corp. engages in the provision of air transportation services. Its brands include jetBlue, jetBlue Vacations, Paisly, and TrueBlue. It operates through the following geographic segments: Domestic and Canada, Caribbean and Latin America, and Atlantic. The company was founded by David Gary Neeleman in August 1998 and is headquartered in Long Island City, NY.

Jetblue Airways Corp

JetBlue is experiencing heightened volatility and trader attention following the collapse of Spirit Airlines, which has prompted aggressive market share expansion efforts and speculation regarding potential industry consolidation. While investors are debating whether the airline can successfully absorb new routes and capitalize on reduced competition, concerns persist regarding its significant debt burden and susceptibility to ongoing fuel price volatility.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors debate the potential for upcoming global expansion announcements following recent comments from leadership, while the community remains divided over the stock's significant short interest and the lack of immediate catalysts. Long-term shareholders are focusing on the company's clinical pipeline and potential for institutional partnerships, even as persistent price volatility fuels intense speculation and frustration within the retail base.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers

Niki BioSolutions (NASDAQ:NIKI) stock moved upwards by 44.7% to $13.01 during Thursday's pre-market session. The company's market cap stands at $73.2 million.
Zhengye Biotechnology (NASDAQ:ZYBT) sharesread more...

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

Zhengye Biotechnology (NASDAQ:ZYBT) shares moved upwards by 24.0% to $1.71 during Wednesday's after-market session. The market value of their outstanding shares is at $135.0 million.
Medpace Holdingsread more...

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers

Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 322.6% to $2.95 during Monday's regular session. The company's market cap stands at $33.0 million.
Advanced Biomed (NASDAQ:ADVB) stock movedread more...

Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results

Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results PR Newswire JILIN, China, April...

Regulatory Wins, Capital Flows, and Global Expansion Drive Market Momentum

A wave of regulatory clarity, strategic financing, and global expansion is reshaping pockets of the market, with companies across biotech, mobility, and emerging healthcare infrastructure positioning for outsized growth. $MGRX, $TOVX, $ZYBT, $FFAI, $TGNT

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Sees Large Decline in Short Interest

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT - Get Free Report) saw a significant decrease in short interest in the month of December. As of December 15th, there was short interest totaling...

Zhengye Biotechnology (NASDAQ:ZYBT) Trading Up 2.8% - What's Next?

Zhengye Biotechnology (NASDAQ:ZYBT) Stock Price Up 2.8% - Should You Buy...

Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. It offers a range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company was founded on March 24, 2023 and is headquartered in Jilin City, China.

Zhengye Biotechnology Holding Ltd. - Ordinary Shares - Class A

Bearish Sentiment

$SNDK

$STX

$SKHY

Memory stocks have been one of the market's most volatile trades this year and are down sharply in recent weeks. Which are you most interested in buying or adding to on this pullback? Vote and explain your reasoning in the comments.

Which memory stock are you most tempted to buy on the pullback: $MU, $SNDK, $STX, or $SKHY? 
 
Drop a comment if you prefer $DRAM or another memory play.

Current Price	$1.35
Prev Close	$1.53
Open	$1.38
Dividend Yield	0.00%
50-Day Moving Average	$1.05
Beta	1.11
Avg. Volume	182,400.75
PE Ratio	-7.44

52-Week High	$13.08
52-Week Low	$0.6155
Market Capitalization	$45.48M
EPS (Annual)	-$0.205
Price to Book	2.03
Revenue Per Employee	$60,176.06

Feed

News

Sentiment

Fundamentals

Info

ZYBTZhengye Biotechnology Holding Ltd

Latest ZYBT News